Colchicine update: 2008
RA Terkeltaub - Seminars in arthritis and rheumatism, 2009 - Elsevier
OBJECTIVES: To review recent advances in the understanding of molecular mechanisms of
drug disposition and cellular mechanisms of action and targets of colchicine, and disease …
drug disposition and cellular mechanisms of action and targets of colchicine, and disease …
Colchicine—update on mechanisms of action and therapeutic uses
Objectives To review the literature and provide an update on the mechanisms of action and
therapeutic uses of oral colchicine in arthritis and inflammatory conditions. Methods We …
therapeutic uses of oral colchicine in arthritis and inflammatory conditions. Methods We …
Colchicine: old and new
A Slobodnick, B Shah, MH Pillinger… - The American journal of …, 2015 - Elsevier
Although colchicine has been a focus of research, debate, and controversy for thousands of
years, the US Food and Drug Administration just approved it in 2009. Over the past decade …
years, the US Food and Drug Administration just approved it in 2009. Over the past decade …
[HTML][HTML] Mechanism of action of colchicine in the treatment of gout
N Dalbeth, TJ Lauterio, HR Wolfe - Clinical therapeutics, 2014 - Elsevier
Purpose The aims of this article were to systematically review the literature about the
mechanism of action of colchicine in the multimodal pathology of acute inflammation …
mechanism of action of colchicine in the multimodal pathology of acute inflammation …
Colchicine in clinical medicine. A guide for internists
G Cocco, DCC Chu, S Pandolfi - European journal of internal medicine, 2010 - Elsevier
Colchicine (COL) has been used in medicine for a long time. It is well recognized as a valid
therapy in acute flares of gouty arthritis, familial Mediterranean fever (FMF), Behçet's …
therapy in acute flares of gouty arthritis, familial Mediterranean fever (FMF), Behçet's …
Colchicine: 1998 update
E Ben-Chetrit, M Levy - Seminars in arthritis and rheumatism, 1998 - Elsevier
OBJECTIVE:: To present an update of the use of colchicine in patients with familial
Mediterranean fever (FMF) and other rheumatic and nonrheumatic diseases. DATA …
Mediterranean fever (FMF) and other rheumatic and nonrheumatic diseases. DATA …
Novel evidence‐based colchicine dose‐reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P‐glycoprotein …
RA Terkeltaub, DE Furst, JL DiGiacinto… - Arthritis & …, 2011 - Wiley Online Library
Objective Drug–drug interactions can limit the safety of colchicine for treating rheumatic
diseases. Seven separate drug–drug interaction (DDI) studies were performed to elucidate …
diseases. Seven separate drug–drug interaction (DDI) studies were performed to elucidate …
Colchicine: an old wine in a new bottle?
F Roubille, E Kritikou, D Busseuil… - Anti-Inflammatory & …, 2013 - ingentaconnect.com
Although colchicine, a natural product, is one of the oldest drugs still currently available, its
possible functions seem to be surprisingly not well-known. Beyond its present medicinal use …
possible functions seem to be surprisingly not well-known. Beyond its present medicinal use …
Colchicine today
E Niel, JM Scherrmann - Joint bone spine, 2006 - Elsevier
Colchicine is used chiefly in the treatment of gout but is also valuable in other inflammatory
diseases such as familial Mediterranean fever (FMF). Three proteins play pivotal roles in …
diseases such as familial Mediterranean fever (FMF). Three proteins play pivotal roles in …
Update on colchicine and its mechanism of action
Y Molad - Current rheumatology reports, 2002 - Springer
Colchicine is a unique anti-inflammatory drug with respect to its limited clinical usefulness
and its mode of action. Colchicine is mainly indicated for the treatment and prophylaxis of …
and its mode of action. Colchicine is mainly indicated for the treatment and prophylaxis of …